Urgent.News

What's breaking now, across hundreds of outlets.

AI

Sources: Isomorphic Labs, an AI drug discovery startup spun out of Google DeepMind, is in early talks to raise funds at a valuation of at least $40B (Bloomberg)

Isomorphic Labs, an AI-powered drug discovery startup spun out of Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to Bloomberg.

The company is focused on using AI for drug discovery.

No further details on the funding talks were reported.

Brief written by urgent.news from 2 reports on this story; may contain errors — check the original.

Source: bloomberg.com

Other reports of this story

Every outlet that reported this, and when →

Read the original at bloomberg.com →

Report a problem with this story

More in AI

I let an AI agent drive my remote desktop. It can't touch my passwords.

It's 11 PM. Three servers need the same patch, and I'm alt-tabbing between four remote windows. Two are RDP, two are VNC.

  • AI agent can view, click, type, and navigate remote desktop.
  • Agent never accesses user passwords or credentials.
  • Agent control limited by time, can be reclaimed instantly.

More from Thursday 8 October →